TNF and psoriasis: To gain insights into the ability of anti-TNF-α treatment to induce epigenetic modifications in vivo, microRNAs (miRNAs), key modulators of gene expression, were analyzed in circulating angiogenic cells (CACs) from psoriasis patients treated with adalimumab.